Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Roivant Sciences

ROIV Healthcare Unknown Updated July 20, 2026
$34.95
52W $10.90 – $37.00
52/100
-75.7
1.11
Explore ROIV Further
📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
AI Committee Verdict
Watch
Conviction: Moderate · 71% agreement · 7 analysts
-23.8%
Moderate
Is ROIV Bullish or Bearish?
Mixed. Innellis AI committee rates Roivant Sciences (ROIV) Watch with a composite score of 52/100 , based on 7 analysts with 71% agreement. Last updated July 20, 2026.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — market regime is bullish (bull market -- normal position sizing). Growth Analyst remains cautious — revenue declining -89.2% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
  • Daily trend: uptrend.
  • Weekly trend: uptrend.
  • Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
  • Higher Highs / Higher Lows structure confirms bullish price action.
  • Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
  • MACD histogram is negative (-0.338) — bearish momentum.
Price History (6M)
AI Investment Committee
Committee Consensus As of July 20, 2026
Overall Committee Score
52/100
Agreement
71%
Analysts
7
Conviction
Moderate
Value Analyst neutral
43 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− Price-to-book of 4.4x prices in significant intangible value
Growth Analyst bearish
40 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -89.2% YoY -- this is not a growth story right now
Technical Analyst neutral
57 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst neutral
58 / 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 17.3% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst neutral
49 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.25 across 4 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2975.52)
Open Full Terminal →
Investment Thesis Evolution

Committee score moved marginally from 51.7 to 51.7.

Analyst-level changes:
  • Portfolio Manager: +1 bearish signal(s).

Comparing 2026-07-19 to 2026-07-20 (1 day apart).

Technical Analysis
RSI (14)
43.9
Neutral
MACD Histogram
-0.338
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.39
Inside Bands
Price vs Moving Averages
EMA 9
$34.67 Above
EMA 21
$34.06 Above
EMA 50
$32.19 Above
EMA 200
$26.03 Above
Fundamental Analysis
Valuation
81
Growth
37
Profitability
0
Financial Health
100
Cash Flow
10
Valuation
P/E Ratio -75.7×
P/B Ratio 5.28×
PEG Ratio 0.90
Dividend Yield 0.00%
52W High $37.00
52W Low $10.90
Quality & Growth
ROE -6.6%
ROA -5.2%
Gross Margin 84.4%
Operating Margin -15560.6%
Revenue Growth YoY
Debt / Equity 0.02
AI Fundamental Assessment
P/E ratio of -75.7 (inexpensive relative to a 15-40x range); Price-to-book of 5.3x; PEG ratio of 0.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.1%; Return on assets of -0.1%; Net margin of -36.3%; Gross margin of 0.8%; Current ratio of 18.37 (healthy short-term liquidity); Debt-to-equity of 0.02; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is negative (-1.08); Most recent quarter missed estimates by 64.6%; 2 consecutive earnings misses; EPS growth accelerating (-123.5% -> -52.6% QoQ); Analyst estimates falling over recent quarters
Key Risks
  • MACD histogram is negative (-0.338) — bearish momentum.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full ROIV Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime